Medicare Payments for Clinical Diagnostic Laboratory Tests in 2020
Medicare is the largest payer of clinical laboratory services in the Nation. Medicare Part B covers most laboratory tests and pays 100 percent of allowable charges. Beneficiaries do not have a copay. The Protecting Access to Medicare Act of 2014 (PAMA) requires CMS to set payment rates for laboratory tests using current charges in the private health care market, under Title XVIII of the Social Security Act. (Pub. L. No. 113-93 § 216(c)(2)(A)). On January 1, 2018, CMS began paying for laboratory tests under the new system mandated by PAMA. PAMA requires OIG to publicly release an annual analysis of the top 25 laboratory tests by expenditures. In accordance with the Act, we will publicly release an analysis of the top 25 laboratory tests by expenditures for 2020.
|Announced or Revised||Agency||Title||Component||Report Number(s)||Expected Issue Date (FY)|
|June 2021||Centers for Medicare and Medicaid Services||Medicare Payments for Clinical Diagnostic Laboratory Tests in 2020||Office of Evaluation and Inspections||OEI-09-21-00240||2022|